Symphony Financial’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $440K | Buy |
+3,774
| New | +$440K | 0.06% | 165 |
|
|
2025
Q1 | – | Sell |
-4,619
| Closed | -$429K | – | 145 |
|
|
2024
Q4 | $429K | Buy |
4,619
+196
| +4% | +$18.2K | 0.07% | 148 |
|
|
2024
Q3 | $370K | Sell |
4,423
-491
| -10% | -$41.1K | 0.06% | 163 |
|
|
2024
Q2 | $338K | Sell |
4,914
-3,423
| -41% | -$236K | 0.06% | 156 |
|
|
2024
Q1 | $611K | Buy |
8,337
+1,580
| +23% | +$116K | 0.14% | 108 |
|
|
2023
Q4 | $581K | Buy |
6,757
+1,791
| +36% | +$154K | 0.13% | 123 |
|
|
2023
Q3 | $368K | Buy |
4,966
+179
| +4% | +$13.3K | 0.09% | 115 |
|
|
2023
Q2 | $364K | Buy |
4,787
+2,031
| +74% | +$154K | 0.09% | 140 |
|
|
2023
Q1 | $224K | Buy |
2,756
+258
| +10% | +$21K | 0.06% | 194 |
|
|
2022
Q4 | $214K | Buy |
+2,498
| New | +$214K | 0.06% | 186 |
|
|
2021
Q2 | – | Sell |
-2,776
| Closed | -$200K | – | 173 |
|
|
2021
Q1 | $200K | Buy |
+2,776
| New | +$200K | 0.05% | 189 |
|